Pharmacological control of gastric acid secretion for the treatment of acid-related peptic disease: past, present, and future.
about
KCNQ1 is the luminal K+ recycling channel during stimulation of gastric acid secretionEvaluation of rational nonsteroidal anti-inflammatory drugs and gastro-protective agents use; association rule data mining using outpatient prescription patterns.The role of protein digestibility and antacids on food allergy outcomes.Tiao He Yi Wei Granule, a Traditional Chinese Medicine, against Ethanol-Induced Gastric Ulcer in Mice.Increased susceptibility of ethanol-treated gastric mucosa to naproxen and its inhibition by DA-9601, an Artemisia asiatica extract.Differentiation of the gastric mucosa. I. Role of histamine in control of function and integrity of oxyntic mucosa: understanding gastric physiology through disruption of targeted genes.No potassium, no acid: K+ channels and gastric acid secretion.Acid peptic diseases: pharmacological approach to treatment.An open-label, randomized, cross-over bioequivalence study of lafutidine 10 mg under fasting conditionAcid suppression therapy and allergic reactions.Lack of histamine alters gastric mucosal morphology: comparison of histidine decarboxylase-deficient and mast cell-deficient mice.Heteromeric KCNE2/KCNQ1 potassium channels in the luminal membrane of gastric parietal cells.Cholinergically stimulated gastric acid secretion is mediated by M(3) and M(5) but not M(1) muscarinic acetylcholine receptors in mice.Essential oil of Croton zehntneri and its major constituent anethole display gastroprotective effect by increasing the surface mucous layer.Effect of Cannabis sativa extract on gastric acid secretion, oxidative stress and gastric mucosal integrity in rats
P2860
Q28593898-7CD90E4E-5194-4D3F-A738-DBC460D07D34Q33870087-D4569A64-B4B5-4F32-94CF-EEBEA53CEA71Q34394239-24AEA16B-5218-481D-9E4E-97FB8622802DQ36392230-B5C30635-F783-4CD9-85E5-291396E76ED0Q36497163-1918DDB3-2C6C-44F5-B676-779742D433F0Q36588770-EA445D33-B6EA-4E2E-9FD4-ECD0A2F5395FQ36967648-A63DAB24-ADA7-4CDD-8524-9C9A7AF38FABQ37913063-1FAFEAC2-2949-47B2-BD31-F8D4947AE274Q41914881-4ED6ADF7-44D6-490C-93E7-E721050AB6A1Q42024011-B9318D1B-6649-4A2C-8B43-88ADFF4507BDQ44991340-89854CBE-5371-474C-A939-D7784E339250Q45173431-F5EF17FB-F3B8-4125-884B-D82DEAEC6CA9Q45251298-EEB72BA6-CDC9-4A44-A940-6E3DEA92AE0CQ46752885-65397BE7-F5AD-4938-BA54-24C4DEE2A44DQ57729842-70AAC459-D832-4365-931D-C1E894D73B8F
P2860
Pharmacological control of gastric acid secretion for the treatment of acid-related peptic disease: past, present, and future.
description
2003 nî lūn-bûn
@nan
2003 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Pharmacological control of gas ...... se: past, present, and future.
@ast
Pharmacological control of gas ...... se: past, present, and future.
@en
type
label
Pharmacological control of gas ...... se: past, present, and future.
@ast
Pharmacological control of gas ...... se: past, present, and future.
@en
prefLabel
Pharmacological control of gas ...... se: past, present, and future.
@ast
Pharmacological control of gas ...... se: past, present, and future.
@en
P2093
P1476
Pharmacological control of gas ...... ase: past, present, and future
@en
P2093
Eiji Nakamura
Kazuyoshi Tomita
Kikuko Amagase
Susumu Okabe
Takeshi Aihara
Teruaki Fujishita
P304
P356
10.1016/S0163-7258(03)00015-9
P577
2003-04-01T00:00:00Z